 |
 |
|
|
|
| Tofacitinib Citrate|540737-29-9 |
 |
| 99.5% |
 |
| 540737-29-9 |
 |
| anti-Arthritis |
 |
Tofacitinib Citrate [CAS:540737-29-9]
Intermediates:
4-Chloro-7H-pyrrolo[2,3-d]pyrimidine [cas:3680-69-1]
(3R,4R)-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine hydrochloride [cas:1062580-52-2]
N-Methyl-N-[(3R,4R)-4-methylpiperidin-3-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine [cas:477600-74-1]
3-[(3R,4R)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-
yl]-3-oxopropanenitrile [cas:477600-75-2]
|
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
